2021 annual financial data
REGENXBIO Inc. 2021 Operating margin
REGENXBIO Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was 34.01%.
Operating income was 159,980,000 USD and net income was 127,840,000 USD.
Operating cash flow was 218,875,000 USD.
Get free REGENXBIO Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 470,347,000 USD
- Operating income
- 159,980,000 USD
- Net income
- 127,840,000 USD
- Operating cash flow
- 218,875,000 USD